The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Conditions: Immunotherapy; Lung Cancer Intervention: Drug: Immunotherapy Sponsor: Guangdong Association of Clinical Trials Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | China Health | Immunotherapy | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | Research | Study